HLMVX
Price
$33.47
Change
+$0.16 (+0.48%)
Updated
Jun 2 closing price
Net Assets
545.9M
NPFCX
Price
$69.71
Change
-$0.41 (-0.58%)
Updated
Jun 3 closing price
Net Assets
164.3B
Interact to see
Advertisement

HLMVX vs NPFCX

Header iconHLMVX vs NPFCX Comparison
Open Charts HLMVX vs NPFCXBanner chart's image
HLMVX vs NPFCX Comparison Chart in %
View a ticker or compare two or three
VS
HLMVX vs. NPFCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLMVX is a Buy and NPFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 164B vs. HLMVX (546M). HLMVX pays higher dividends than NPFCX: HLMVX (0.51) vs NPFCX (0.33). HLMVX was incepted earlier than NPFCX: HLMVX (17 years) vs NPFCX (25 years). NPFCX (1.47) is less costly to investors than HLMVX (0.88). HLMVX is a more actively managed with annual turnover of: 30.00 vs. NPFCX (23.00). NPFCX has a lower initial minimum investment than HLMVX: NPFCX (250) vs HLMVX (100000). NPFCX annual gain was more profitable for investors over the last year : 12.77 vs. HLMVX (-5.75). NPFCX return over 5 years is better than : 13.27 vs. HLMVX (-32.28).
HLMVXNPFCXHLMVX / NPFCX
Total Expense Ratio0.861.4759%
Annual Report Gross Expense Ratio0.881.4760%
Fund Existence17 years25 years-
Gain YTD6.2187.03788%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets546M164B0%
Annual Yield % from dividends0.510.33156%
Returns for 1 year-5.7512.77-45%
Returns for 3 years-5.2240.04-13%
Returns for 5 years-32.2813.27-243%
Returns for 10 years8.76103.068%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCS25.280.76
+3.10%
Barclays PLC
IFS50.440.29
+0.58%
Intercorp Financial Services
EHLD8.80-0.09
-1.01%
Euroholdings Ltd
PAHC28.50-1.38
-4.60%
Phibro Animal Health Corp
AKBA0.94-0.08
-8.20%
Akebia Therapeutics